BioSpace News Archive

Aerie Pharmaceuticals, Inc. today announced that the first participant has been dosed in the Phase 3 registrational “COMET-2” study to evaluate AR-15512 ophthalmic solution as a treatment for the signs and symptoms of dry eye disease (DED).

Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, will participate in the 2022 Jefferies Healthcare Conference June 8-10, 2022. Antonin de Fougerolles, Ph.D., Chief Executive Officer of Evox Therapeutics, will present on Friday, June 10 at 11:30 a.m. EDT and will host 1x1 meetings at and around the conference in New York.

scPharmaceuticals Inc. announced that John Tucker, president & chief executive officer, is scheduled to present at the Jefferies Healthcare Conference on Thursday, June 9 at 2:00pm EDT at the Marriott Marquis in New York City.

uniQure N.V. (NASDAQ: QURE), today announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review the Biologics License Application (BLA) submitted by CSL Behring for etranacogene dezaparvovec, an investigational gene therapy for the treatment of adults with hemophilia B.

Travecta Therapeutics, Pte Ltd. today announced that Donald C. Manning , MD, PhD, Chief Medical Officer and Head of Research and Development, will present at the 2022 BIO International Convention occurring June 13-16, 2022 in San Diego, CA.

FDA Accepts CSL Behring’s Biologics License Application for Etranacogene Dezaparvovec for Priority Review.

Incyte announced that it will present at the 43rd Annual Goldman Sachs Global Healthcare Conference on Tuesday, June 14, 2022 at 8:00 a.m. /11 a.m. in Rancho Palos Verdes.

Data to be Presented in Heavily Pretreated MSS-CRC Speed and Innovation Core to Development Strategy Reduction of 20% in 2022 Operating Costs.

Nanalysis Announces First Quarter 2022 Conference Call and Virtual Annual General Meeting,

Signati™ Medical, Inc. is pleased to announce the unveiling of their innovative Sealed Vasectomy Procedure at this year’s AUA Annual Meeting in New Orleans, LA.